TARDBP and cerebrovascular disorder: Further, this study did not account for the contributions of certain pathologic features (e.g., TDP-43, cerebrovascular disease, degree of neuronal loss) relevant to both cognitive impairment and the degree of neurofibrillary degeneration [19, 30, 59, 60].